Founded in 2014, PharmaCann is the largest vertically-integrated and unified medical cannabis company operating in highly regulated states. With over 160 professionals, 8 dispensaries and 3 cultivation sites, we are focused on growth and pursuing emerging market opportunities everyday, including new states and licenses.
PharmaCann is built upon a commitment to superior professionalism and strong ethical standards. The Company is proud to have been awarded the highest ranked license issued by the state of New York and is the largest holder of medical cannabis licenses in Illinois. Through collaboration with the medical community, PharmaCann's intent is to reduce the stigma associated with medical cannabis and develop research that will help prove the benefits and efficacy of cannabis as medicine.
PharmaCann's aim is to be the leader in cultivating and dispensing medical cannabis to promote a better quality of life for patients in need. The Company's cultivation sites use controlled growing systems and high quality formulation and production. PharmaCann is currently developing a non-commoditized portfolio of products to be competitive in this fast growing industry. Its dispensary staff is dedicated to providing individualized care for each patient in conjunction with his or her healthcare practitioner. PharmaCann focuses on education so its patients understand all aspects of medical cannabis including their rights and responsibilities based on the state in which they reside.
Mission & Vision
PharmaCann's mission is to lead the medical cannabis industry with respect to the quality of its employees, facilities, products and research and development efforts to discover the true scientific benefits of medical cannabis for suffering patients.
PharmaCann's vision is to improve the quality of life for patients in need through discovery, cultivation and responsible dispensing of cannabis-related medicine. PharmaCann seeks to lead in the science-based understanding of the full impact of medical cannabis for the healthcare industry.
- Awarded six Illinois licenses (most in Illinois) among limited number of license award winners
- Only company in Illinois with multiple manufacturing and dispensary licenses
- Near 80% of Illinois market (Chicagoland)
- Awarded licenses for five facilities
- #1 ranked score in New York (43 applicants)
- 1 of 5 companies awarded licenses in the state
- 1 of 4 in NYC (Bronx Dispensary)
- 127,572 sf state of the art manufacturing facility
PharmaCann's team is comprised of individuals devoted to making medical cannabis accessible to patients. With a wide range of backgrounds in areas such as business, law, accounting, science and retail, the Company is well-suited to address the challenges of a rapidly changing industry. PharmaCann has become known in the medical cannabis sector as national thought leaders and respected research partners.
Mike ChodilMike Chodil joined PharmaCann in June 2016 where he oversees cultivation, processing and dispensary operations. Mike has over 20 years of experience in business management, operations and finance. Before joining PharmaCann, Mike worked at Knight Capital Group/GETCO, Hewitt Associates and Comdisco where he focused on cost and data management, financial planning and analysis, risk management and sales operations. Mike earned his Bachelors degree in Biomedical Engineering from the University of Iowa and a Masters degree in Finance and Accounting from University of Illinois at Chicago.
Chris DiorioChris Diorio joins PharmaCann as a New York State registered pharmacist focusing on Product Development & Manufacturing. He brings over 25 years experience in Big Pharma R&D and manufacturing with previous leadership positions as Pfizer/Capsugel, Wyeth and Lederle. His broad experience includes early dosage form development activities through commercial product launch with prescription pharmaceuticals, generics, consumer products and dietary supplements. He is the co-inventor on over 20 patents, with a large focus on drug and ingredient/active delivery technologies. Chris attended Long Island University where he received a Bachelors degree in Pharmacy and a Masters degree in Pharmaceutical Science. He also holds a degree in environmental biology from SUNY College of Environmental Science.
Mary GeminiMary Gemini joined PharmaCann in August of 2015 as the Director of Illinois Retail Operations where she oversees four dispensaries while creating a strong group of professionals through training, coaching, mentoring and development. Mary has over 25 years of experience in retail management and sales and operations. At her previous position at Wal-Mart, she served as a team leader to over 300 employees. She was also an active member in a Women in Leadership Forum within the organization.
Johnny HernandezJohnny Hernandez brings over ten years of experience as the Director of Technology for PharmaCann. Treating technology as a cornerstone for business operations, the experience Johnny brings to the team focuses on the management, strategy, and execution of IT infrastructure for the organization. Prior to joining PharmaCann, Johnny spent time in both private and public sectors. His career began as a co-creator of three successful STEM programs for Chicago Mayor Richard Daley's After School Matters program. The programs attracted major corporate sponsorship from Motorola and BP. In his private sector work, Johnny not only owned his own consulting business but also worked with a private equity/family office to create a secure, flexible network infrastructure. Johnny holds numerous certifications, including Google Apps Administration and Cisco Certified Routing and Switching.
Brendon HersheyBrendon Hershey has over nine years experience in the horticulture industry, holding various roles in horticulture production, operations and R&D. Prior to joining PharmaCann as the Cultivation Manager, Brendon worked as a Greenhouse Operations Manager in the Controlled Environments Department at DuPont Pioneer, where he supported crop genetics research and specialized in greenhouse automation, operations and production efficiency. Brendon earned his Bachelor of Science in Agri-business Management at the University of Delaware.
Sue MullinSue Mullin is PharmaCann's Director of Human Resources bringing over 25 years of senior HR leadership experience in Global Fortune 2000 information services, consulting and manufacturing. Prior to joining PharmaCann, Sue worked at Wolters Kluwer, CCH Incorporated and Northrop Grumman. She brings extensive experience in developing performance management programs, designing organizational structures, directing talent acquisition, executive coaching, change management, employee relations and compensation management. Sue attended Roosevelt University where she received a Bachelors degree in English Studies and holds CCP and SPHR designations.
Brett NoveyBrett Novey is PharmaCann's Director of Finance. Brett has over fifteen years of experience across multiple disciplines including corporate finance and corporate restructuring. Prior to joining PharmaCann, Brett was the Head of Financial Planning & Analysis for Knight Capital Group, where he was responsible for cash/capital management, monthly forecasting and the annual budgeting process. Prior to KCG, Brett worked for Sears Holdings, where he was the Director of Finance for the $1 billion Craftsman brand. At Craftsman, Brett led the initial efforts to wholesale Craftsman branded products to third-party retailers (i.e., non-Sears store formats) for the first time in Sears' history. Brett also previously advised clients on financial and operational restructuring during his tenure at KMPG and Arthur Andersen. Brett earned his Bachelors degree in Accounting and Finance from Indiana University, and a Masters degree from Northwestern's Kellogg School of Management.
Anna PoulinAnna Poulin joins PharmaCann as the Manager of Physician and Patient Outreach with over 18 years of extensive sales and marketing experience from the pharmaceutical industry. Anna worked in the areas of neuroscience, cardiovascular, wound care, pain management, oncology and gastroenterology. As an Area Sales Manager for Novartis, she led their midwest region sales force. While at Novartis, Anna developed “thought leaders” in the Neuroscience and Cardiovascular areas. At Exact Sciences Corporation she worked with Chief Medical Officers from local health systems to integrate their product into EMRs. Her experience also includes having spent time as a National Trainer, developing and implementing training programs for Sales Specialists and District Managers. Anna attended Loyola University and she joined PharmaCann with the belief that every patient has the right to have access to the best available medicine for their condition. It is her mission to be part of the this successful movement.
Rachel SchepartRachel Schepart joins PharmaCann as the Lead Pharmacist & Director of Retail Sales and Operations and currently oversees operations of four Dispensaries in New York. She has over 20 years experience in palliative care, hospice management, home infusion patient care and retail pharmacy and has held positions at Caremark Homecare, Eckerd Drugs, American Home Patient, Coram Healthcare and Rite Aid. Rachel earned her Bachelor of Science and Pharmacy Management Certificate from State University of New York at Buffalo.
Stephen SchulerStephen Schuler, a serial entrepreneur, co-founded GETCO LLC, one of the first and most successful electronic trading firms. In 2013, GETCO acquired Knight Capital Group and created the publicly traded company KCG Holdings, Inc. Stephen is a former Director at KCG and current Director at Wicklow Capital, which focuses on early stage to pre IPO investment opportunities.
Teddy ScottTeddy Scott co-founded PharmaCann in 2014. Prior to PharmaCann, Teddy was an equity partner at Polsinelli PC, an American Lawyer Top-100 law firm representing pharmaceutical and biotech companies in the development and commercialization of FDA-approved therapies. Teddy is also a co-founder of Accelerated Pharma, Inc., a pharmaceutical company based on rediscovery, repurposing and re-launching previously unsuccessful drug candidates and serves as outside counsel and advisor for MATTER, a med-tech startup incubator in Illinois. He is also on the Board of Advisors for the University of Chicago Innovation Fund. Teddy earned his Ph.D. in molecular biophysics from University of Texas Southwestern Medical Center at Dallas and his J.D. from Northwestern University School of Law.
Jeremy UnruhJeremy Unruh brings a fifteen-year track record as a government prosecutor to the nascent medical cannabis industry. Before joining PharmaCann as Director of External Communications & General Counsel, Jeremy worked at the Office of the State's Attorney before opening a private practice where he focused on commercial litigation, internal compliance investigations in the financial services and healthcare industries and product liability defense for large industrial manufacturers. Presently, Jeremy oversees the security and warehousing functions of the cultivation centers and manages the build out and point-of-sale operations of PharmaCannis dispensaries while also providing legal support to the company as needed. Jeremy earned a Bachelors degree from Kansas State University, a Masters degree from DePaul University's Kellstadt School of Business Management and a Juris Doctor from Washburn University School of Law.
Are you passionate about helping people in a new and exciting industry? If so, PharmaCann wants to meet you.
PharmaCann is full of new opportunities, and is looking for experienced professionals in the following departments:
- Corporate Security
- Cultivation & Processing
- Warehousing & Distribution
- Sales & Marketing
1010 Lake Street, Second Floor
Oak Park, IL 60301